Paola Conigliaro

Paola Conigliaro

Auto-generated profile, based on publicly available information

Paola Conigliaro

Italian National Institute of Statistics–Istat, Rome, Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2023 in Rheumatology and Therapy
Verified
Journal Article
Open access
PDF file
Ennio LubranoEnnio Lubrano
Ennio Lubrano
SSSilvia Scriffignano
Silvia Scriffignano
MFMauro Fatica
Mauro Fatica
PTPaola Triggianese
Paola Triggianese
PCPaola Conigliaro
Paola Conigliaro
MCMaria Sole Chimenti
Maria Sole Chimenti
Objective To assess any differences and similarities in psoriatic arthritis (PsA) between sexes. Any possible differences of psoriasis and its potential impact on disease burden between sexes with PsA were also evaluated. Methods Cross-sectional analysis of two longitudinal PsA cohorts. The impact of psoriasis on the PtGA was evaluated. Patients were stratified in four groups based on BSA. The median PtGA was then compared between the four groups. Moreover, a multivariate linear regression analysis was performed in order to evaluate associations between PtGA and skin involvement, split by sexes. Results We enrolled 141 males and 131 females: PtGA, PtPnV, tender, swollen joint count, DAPSA, HAQ-DI, PsAID-12 were statistically significant higher in females (p ≤ 0.05). PASS “yes” was deemed more in males than in females and BSA was higher in males. MDA was present more in males than females. When the patients were stratified on BSA, median PtGA was not different between males and females with BSA = 0. Instead, in females with BSA > 0, a higher PtGA was observed compared to males with BSA > 0. There was not a statistically significant association between skin involvement and PtGA at linear regression analysis, even if a trend seems to be present in female. Conclusions Psoriasis is more present in males, but it seems to be related to a worse impact in females. In particular, a possible role of psoriasis as an influencing factor the PtGA was found. Moreover, female PsA patients tended to have more disease activity, worse function, and higher disease burden.

5 January 2021 in Social Indicators Research
Verified
Journal Article
Closed access
PDF file
PCPaola Conigliaro
Paola Conigliaro

7 June 2020 in Social Indicators Research
Verified
Journal Article
Closed access
PDF file
PCPaola Conigliaro
Paola Conigliaro

16 September 2023 in Rheumatology and Therapy
Verified
Journal Article
Open access
PDF file
SSSilvia Scriffignano
Silvia Scriffignano
FPFabio Massimo Perrotta
Fabio Massimo Perrotta
PCPaola Conigliaro
Paola Conigliaro
MFMario Ferraioli
Mario Ferraioli
PTPaola Triggianese
Paola Triggianese
Ennio LubranoEnnio Lubrano
Ennio Lubrano
Introduction The aim of this work is to characterize which Minimal Disease Activity (MDA) domains are mainly achieved, based on different treatments, in psoriatic arthritis (PsA) patients. Moreover, the association between MDA achievement and the different treatment groups was assessed. Methods We conducted a cross-sectional analysis of two longitudinal PsA groups. Inclusion criteria were: age ≥ 18 years, PsA diagnosis, stable treatment for at least 6 months. Patients were grouped depending on the therapy: group 1: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)/cyclooxygenase 2 inhibitors (COX2i)/steroids, group 2: conventional synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs), group 3: Tumor Necrosis Factor α inhibitors (TNFi), group 4: interleukin inhibitors (IL)12-23i or IL-23i, group 5: IL-17i, group 6: phosphodiesterase 4 inhibitors (PD4i). For each group, the achieved domains based on therapy were assessed. Multivariate logistic regression analysis was performed to assess the association between the treatment groups and the MDA achievement. Results A total of 220 patients were enrolled, and MDA was achieved in 45.8% of them. In all treatment groups, the first MDA domains achieved were: body surface area ≤ 3, swollen joint count ≤ 1 and Leeds Enthesitis Index ≤ 1, while MDA domains less frequently achieved were Patient Global Assessment (PtgA) ≤ 2 cm and pain on visual analogue scale ≤ 1.5 cm. The logistic regression analysis showed higher odds ratios for the achievement of the MDA in those patients in groups 3 and 4. Conclusions In each treatment group, MDA domains less frequently achieved were PtGA and pain, suggesting that “patient-driven domains” are still an unmet need. Due to the study design and the low number of patients in some groups, it is not possible to clearly define which MDA domain was achieved or not based on treatment; however, it seems that some differences could be present. If larger and prospective studies confirm our preliminary results, we could move toward a personalized/domain treatment approach in PsA.

2 March 2021
Verified
Book Chapter
Closed access
PDF file
LALeonardo Salvatore Alaimo
Leonardo Salvatore Alaimo
PCPaola Conigliaro
Paola Conigliaro